A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as ...

Under NIR irradiation, MPDA/B@M’s photothermal effect directly eradicates pathogens while upregulating HSP70 to enhance host inflammation tolerance. This synergizes with bufalin’s anti-inflammatory ...

A new study suggests low-intensity ultrasound can influence immune cell behavior in ways that may reduce chronic inflammation ...

Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...

Scientists say they have built a cell from scratch for the first time that can feed, grow and replicate like a natural cell.

An excellent debut, the Motorola Razr Fold is a well-rounded foldable phone that even lets you do big-screen activities on a ...

Hypertrophic scars (HS) are abnormal outcomes of wound healing, marked by excessive extracellular matrix (ECM) deposition and ...

Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a ...

Researchers found that loss of GATA6 reprograms colorectal cancer cells into flexible, fetal-like states that can spread to ...